New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
09:27 EDTNAVBNavidea announces collaboration with Maimonides Medical Center
Navidea Biopharmaceuticals has entered into an agreement to collaborate with Maimonides Medical Center to investigate the utility of Lymphoseek Injection in lymphatic mapping procedures for colorectal cancer. Dr. Danny Sherwinter, surgeon and the Director of the Department of Minimally Invasive & Bariatric Surgery at Maimonides Medical Center in Brooklyn, NY, will lead the investigator-initiated clinical study. This open-label evaluation, expected to start enrollment in early 2013, will be performed at Maimondes and will include the assessment of lymph nodes from up to 40 colon cancer subjects. According to the American Cancer Society, approximately 140,000 new cases of colorectal cancer are expected to be diagnosed in the United States annually1 while worldwide annual diagnosis is over 1.2 million.
News For NAVB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 12, 2015
07:32 EDTNAVBNavidea reaffirms $10M-$12M Lymphoseek revenue guidance for 2015
Subscribe for More Information
07:31 EDTNAVBNavidea reports Q1 EPS (5c), consensus (3c)
Subscribe for More Information
May 11, 2015
19:15 EDTNAVBOn The Fly: After Hours Movers
Subscribe for More Information
17:22 EDTNAVBNavidea secures $60M loan with CRG
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use